Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Review Article

Overcoming Low Adherence to Chronic Medications by Improving their Effectiveness using a Personalized Second-generation Digital System

Author(s): Areej Bayatra, Rima Nasserat and Yaron Ilan*

Volume 25, Issue 16, 2024

Published on: 26 January, 2024

Page: [2078 - 2088] Pages: 11

DOI: 10.2174/0113892010269461240110060035

Price: $65

Abstract

Introduction: Low adherence to chronic treatment regimens is a significant barrier to improving clinical outcomes in patients with chronic diseases. Low adherence is a result of multiple factors.

Methods: We review the relevant studies on the prevalence of low adherence and present some potential solutions.

Results: This review presents studies on the current measures taken to overcome low adherence, indicating a need for better methods to deal with this problem. The use of first-generation digital systems to improve adherence is mainly based on reminding patients to take their medications, which is one of the reasons they fail to provide a solution for many patients. The establishment of a second-generation artificial intelligence system, which aims to improve the effectiveness of chronic drugs, is described.

Conclusion: Improving clinically meaningful outcome measures and disease parameters may increase adherence and improve patients' response to therapy.

Graphical Abstract


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy